160 related articles for article (PubMed ID: 20978184)
1. PPARγ-independent thiazolidinedione-mediated inhibition of NUR77 expression in vascular endothelial cells.
Hu Y; Liu HB; Simpson RW; Dear AE
J Endocrinol; 2011 Jan; 208(1):R1-7. PubMed ID: 20978184
[TBL] [Abstract][Full Text] [Related]
2. Thiazolidinediones inhibit TNFalpha induction of PAI-1 independent of PPARgamma activation.
Liu HB; Hu YS; Medcalf RL; Simpson RW; Dear AE
Biochem Biophys Res Commun; 2005 Aug; 334(1):30-7. PubMed ID: 15990085
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor γ agonist troglitazone inhibits high mobility group box 1 expression in endothelial cells via suppressing transcriptional activity of nuclear factor κB and activator protein 1.
Gao M; Hu Z; Zheng Y; Zeng Y; Shen X; Zhong D; He F
Shock; 2011 Sep; 36(3):228-34. PubMed ID: 21617575
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 attenuates tumour necrosis factor-alpha-mediated induction of plasminogen [corrected] activator inhibitor-1 expression.
Liu H; Hu Y; Simpson RW; Dear AE
J Endocrinol; 2008 Jan; 196(1):57-65. PubMed ID: 18180317
[TBL] [Abstract][Full Text] [Related]
5. A novel thiazolidinedione MCC-555 down-regulates tumor necrosis factor-alpha-induced expression of vascular cell adhesion molecule-1 in vascular endothelial cells.
Kurebayashi S; Xu X; Ishii S; Shiraishi M; Kouhara H; Kasayama S
Atherosclerosis; 2005 Sep; 182(1):71-7. PubMed ID: 16115476
[TBL] [Abstract][Full Text] [Related]
6. Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function.
Kato K; Satoh H; Endo Y; Yamada D; Midorikawa S; Sato W; Mizuno K; Fujita T; Tsukamoto K; Watanabe T
Biochem Biophys Res Commun; 1999 May; 258(2):431-5. PubMed ID: 10329404
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome-proliferator-activated receptor gamma (PPARgamma) is required for modulating endothelial inflammatory response through a nongenomic mechanism.
Cantini G; Lombardi A; Borgogni E; Francalanci M; Ceni E; Degl'Innocenti S; Gelmini S; Poli G; Galli A; Serio M; Forti G; Luconi M
Eur J Cell Biol; 2010 Sep; 89(9):645-53. PubMed ID: 20537761
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.
Hamaguchi E; Takamura T; Shimizu A; Nagai Y
J Pharmacol Exp Ther; 2003 Dec; 307(3):987-94. PubMed ID: 14534369
[TBL] [Abstract][Full Text] [Related]
9. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
10. PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.
Scoditti E; Massaro M; Carluccio MA; Distante A; Storelli C; De Caterina R
Cardiovasc Res; 2010 May; 86(2):302-10. PubMed ID: 20032081
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide.
Sommer M; Wolf G
Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator activated receptor gamma agonists suppress TNFalpha-induced ICAM-1 expression by endothelial cells in a manner potentially dependent on inhibition of reactive oxygen species.
Jung Y; Song S; Choi C
Immunol Lett; 2008 Apr; 117(1):63-9. PubMed ID: 18206249
[TBL] [Abstract][Full Text] [Related]
13. Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium.
Chen NG; Han X
Biochem Biophys Res Commun; 2001 Apr; 282(3):717-22. PubMed ID: 11401521
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma (PPARgamma): Is the genomic activity the only answer?
Luconi M; Cantini G; Serio M
Steroids; 2010; 75(8-9):585-94. PubMed ID: 19900469
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists.
Antonelli A; Ferrari SM; Fallahi P; Frascerra S; Piaggi S; Gelmini S; Lupi C; Minuto M; Berti P; Benvenga S; Basolo F; Orlando C; Miccoli P
Endocr Relat Cancer; 2009 Dec; 16(4):1299-311. PubMed ID: 19755523
[TBL] [Abstract][Full Text] [Related]
16. TNFalpha- and NF-kappaB-dependent induction of the chemokine CCL1 in human macrophages exposed to the atherogenic lipoprotein(a).
N'Diaye M; Le Ferrec E; Kronenberg F; Dieplinger H; Le Vee M; Fardel O
Life Sci; 2009 Mar; 84(13-14):451-7. PubMed ID: 19302817
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
[TBL] [Abstract][Full Text] [Related]
18. Butyrate inhibits cytokine-induced VCAM-1 and ICAM-1 expression in cultured endothelial cells: the role of NF-kappaB and PPARalpha.
Zapolska-Downar D; Siennicka A; Kaczmarczyk M; Kołodziej B; Naruszewicz M
J Nutr Biochem; 2004 Apr; 15(4):220-8. PubMed ID: 15068815
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.
Bonofiglio D; Qi H; Gabriele S; Catalano S; Aquila S; Belmonte M; Andò S
Endocr Relat Cancer; 2008 Jun; 15(2):545-57. PubMed ID: 18509005
[TBL] [Abstract][Full Text] [Related]
20. Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones.
Weng JR; Chen CY; Pinzone JJ; Ringel MD; Chen CS
Endocr Relat Cancer; 2006 Jun; 13(2):401-13. PubMed ID: 16728570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
